Details of the Drug

General Information of Drug (ID: DMUXLWK)

Drug Name

CTP-499

Indication

Disease Entry	ICD 11	Status	REF
Diabetic nephropathy	GB61.Z	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C13H20N4O3
Canonical SMILES: CC(CCCCN1C(=O)C2=C(N=CN2C)N(C1=O)C)O
InChI: 1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m0/s1/i1D3,6D2
InChIKey: NSMXQKNUPPXBRG-WHPHVCHMSA-N

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01487109) A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients. U.S. National Institutes of Health.